Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab
Clinical trial NCT02275156 · COMPLETED
Trial details
- NCT number
- NCT02275156
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-19
- Primary completion
- 2014-12-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.